Share
 
Title
Code
Session Type
Format
ROOM/CHANNEL
Date Time
Co-Chairs
Organizer

Novel multi-purpose prevention technologies (MPTs) will require governments, funders, implementing partners, healthcare providers and potential users to reimagine how HIV and family planning (FP) products and programs are designed, delivered and monitored. The Dual Prevention Pill (DPP), a daily pill containing oral PrEP and combined oral contraception, is furthest along in development and could be introduced in 2024. This session will convene an interactive program to discuss how to practically align HIV and FP programs and services to deliver the DPP. Speakers will present new insights from human-centered design (HCD) research on potential DPP users as a foundation for demand generation plans; discuss the process for developing provider counseling messages for the DPP as a model for other MPTs; and share the design of cost-effectiveness modelling approaches to bridge FP and HIV prevention. How lessons from HIV and FP can shape DPP introduction and accelerate the rollout of future MPTs will also be discussed.

17:45
10 min
Introduction: Preparing for a future with a range of MPT options
Jessica RODRIGUES, AVAC, United States
17:55
15 min
Who is most likely to use the DPP and how might we engage them effectively? Using HCD research to design demand generation and marketing plans for the DPP
Wawira NYAGAH, AVAC, Kenya
18:10
15 min
How can providers counsel on the DPP as a novel, combined product? Recommendations and process for reconciling oral PrEP and COC counseling guidance
Dr. Lisa B. HADDAD, Population Council, United States
18:25
15 min
Cost-effectiveness of the DPP for HIV and contraception across different populations in Western Kenya and South Africa
Anna BERSHTEYN, New York University School of Medicine, United States
18:40
30 min
Panel: How can planning for the DPP help build platforms for future MPTs? Integrating HIV and FP programs to accelerate delivery of new MPTs with proven approaches
Wawira NYAGAH, AVAC, Kenya
Dr. Lisa B. HADDAD, Population Council, United States
Samukeliso DUBE, FP2030, South Africa
Nyaradzo Mavis MGODI, University of Zimbabwe, Zimbabwe
Anna BERSHTEYN, New York University School of Medicine, United States
Jessica RODRIGUES, AVAC, United States
19:10
5 min
Key takeaways: Ingredients for the successful rollout of MPTs
Jessica RODRIGUES, AVAC, United States